|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
611913410 |
| 003 |
DE-627 |
| 005 |
20240421012310.0 |
| 007 |
tu |
| 008 |
091029s2010 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2009940801
|
| 020 |
|
|
|a 9781603274173
|9 978-1-60327-417-3
|
| 035 |
|
|
|a (DE-627)611913410
|
| 035 |
|
|
|a (DE-576)312377053
|
| 035 |
|
|
|a (DE-599)BSZ312377053
|
| 035 |
|
|
|a (OCoLC)698894177
|
| 035 |
|
|
|a (OCoLC)698894177
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a QP624.75.D77
|
| 082 |
0 |
|
|a 615/.7045
|q LOC
|2 22
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a WD 4150
|2 rvk
|0 (DE-625)rvk/148177:
|
| 084 |
|
|
|a WC 4150
|2 rvk
|0 (DE-625)rvk/148092:
|
| 084 |
|
|
|a 42.13
|2 bkl
|
| 084 |
|
|
|a 44.41
|2 bkl
|
| 084 |
|
|
|a 44.42
|2 bkl
|
| 090 |
|
|
|a a
|
| 245 |
1 |
0 |
|a Drug-DNA interaction protocols
|c ed. by Keith R. Fox
|
| 250 |
|
|
|a 2. ed.
|
| 264 |
|
1 |
|a New York
|a Heidelberg [u.a.]
|b Humana Press
|c 2010
|
| 300 |
|
|
|a XI, 318 S.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in molecular biology
|v 613
|
| 490 |
0 |
|
|a Springer protocols
|
| 500 |
|
|
|a Literaturangaben
|
| 505 |
8 |
0 |
|t 1. Quantitative analysis of small molecule-nucleic acid interactions with a biosensor surface and surface plasmon resonance detection
|r Yang Liu and W. David Wilson
|
| 505 |
8 |
0 |
|t 2. Thermal melting studies of ligand DNA interactions
|r Aurore Guédin, Laurent Lacroix, and Jean-Louis Mergny
|
| 505 |
8 |
0 |
|t 3. Circular and linear dichroism of drug-DNA systems
|r Alison Rodger
|
| 505 |
8 |
0 |
|t 4. Drug binding to DNA-RNA hybrid structures
|r Richard T. Wheelhouse and Jonathan B. Chaires
|
| 505 |
8 |
0 |
|t 5. Quantification of binding data using capillary electrophoresis
|r Fitsumbirhan Araya, Graham G. Skellern, and Roger D. Waigh
|
| 505 |
8 |
0 |
|t 6. Determination of equilibrium association constants of ligand-DNA complexes by electrospray mass spectrometry
|r Valérie Gabelica
|
| 505 |
8 |
0 |
|t 7. Detection of adriamycin-DNA adducts by accelerator mass spectrometry
|r Kate Coldwell ... [et al.]
|
| 505 |
8 |
0 |
|t 8. Molecular modelling methods to quantitate drug-DNA interactions
|r Hao Wang and Charles A. Laughton
|
| 505 |
8 |
0 |
|t 9. Application of anomalous diffraction methods to the study of DNA and DNA-complexes
|r Derrick Watkins ... [et al.]
|
| 505 |
8 |
0 |
|t 10. DNase I footprinting
|r Antonia S. Cardew and Keith R. Fox
|
| 505 |
8 |
0 |
|t 11. Methods to characterize the effect of DNA-modifying compounds on nucleosomal DNA
|r Vidya Subramanian ... [et al.]
|
| 505 |
8 |
0 |
|t 12. REPSA: combinatorial approach for identifying preferred drug-DNA binding sequences
|r Michael W. Van Dyke
|
| 505 |
8 |
0 |
|t 13. In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequences
|r Benny J. Evison, Don. R. Phillips, and Suzanne M. Cutts
|
| 505 |
8 |
0 |
|t 14. In virtro footprinting of promoter regions within supercoiled plasmid DNA
|r Daekyu Sun
|
| 505 |
8 |
0 |
|t 15. Topoisomerase I-mediated DNA relaxation as a tool to study intercalation of small molecules and supercoiled DNA
|r Paul Peixoto ... [et al.]
|
| 505 |
8 |
0 |
|t 16. A high-throughput assay for DNA topoisomerases and other enzymes based on DNA triplex formation
|r Matthew R. Burrell, Nicolas P. Burton and Anthony Maxwell
|
| 505 |
8 |
0 |
|t 17. Measurement of DNA interstrand crosslinking in individual cells using the single cell gel electrophoresis (Comet) assay
|r Victoria J. Spanswick, Janet M. Hartley, and John A. Hartley
|
| 505 |
8 |
0 |
|t 18. Measurement of DNA interstrand crosslinking in naked DNA using Gel-based methods
|r Konstantinous Kiakos, Janet M. Hartley, and John A. Hartley
|
| 505 |
8 |
0 |
|t 19. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells
|r Mekala Gunaratnam and Stephen Neidle.
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|h DE-31
|x XA-DE-BW
|2 pdager
|5 DE-352
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20240324
|f DE-4165
|z 1
|2 pdager
|
| 650 |
|
0 |
|a DNA-drug interactions
|
| 650 |
|
2 |
|a DNA
|x drug effects
|v Laboratory Manuals
|
| 650 |
|
2 |
|a DNA Footprinting
|x methods
|v Laboratory Manuals
|
| 650 |
|
2 |
|a Polymerase Chain Reaction
|x methods
|v Laboratory Manuals
|
| 650 |
|
2 |
|a DNA Probes
|v Laboratory Manuals
|
| 650 |
|
2 |
|a DNA-Binding Proteins
|v Laboratory Manuals
|
| 650 |
|
2 |
|a Pharmaceutical Preparations
|x metabolism
|v Laboratory Manuals
|
| 650 |
|
2 |
|a DNA
|x metabolism
|v Laboratory Manuals
|
| 650 |
|
2 |
|a DNA
|x chemistry
|v Laboratory Manuals
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4070512-2
|0 (DE-627)106099922
|0 (DE-576)209181206
|a DNS
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4003115-9
|0 (DE-627)106390619
|0 (DE-576)208850325
|a Arzneimittel
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4170397-2
|0 (DE-627)104653191
|0 (DE-576)209930004
|a Molekularpharmakologie
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Fox, Keith R.
|e hrsg
|4 edt
|
| 776 |
1 |
|
|z 9781603274180
|
| 776 |
0 |
8 |
|i Online-Ausg.
|a Fox, Keith R.
|t Drug-DNA Interaction Protocols
|d Totowa, NJ : Humana Press, 2010
|h Online-Ressource (digital)
|w (DE-627)1650791623
|w (DE-576)338474781
|z 9781603274180
|
| 830 |
|
0 |
|a Methods in molecular biology
|v 613
|9 613
|w (DE-627)131029002
|w (DE-576)010864504
|w (DE-600)1095346-2
|x 1064-3745
|7 ns
|
| 856 |
4 |
2 |
|u http://www.loc.gov/catdir/enhancements/fy1011/2009940801-d.html
|x Verlag
|3 Verlagsangaben
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/611913410.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 912 |
|
|
|a GBV_ILN_55
|
| 912 |
|
|
|a ISIL_DE-Goe116
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a ISIL_DE-9
|
| 912 |
|
|
|a GBV_ILN_290
|
| 912 |
|
|
|a ISIL_DE-D267
|
| 912 |
|
|
|a GBV_ILN_2007
|
| 912 |
|
|
|a ISIL_DE-352
|
| 935 |
|
|
|i sf
|
| 935 |
|
|
|i Blocktest
|
| 936 |
r |
v |
|a WD 4150
|b Molekularbiologie (hier nur einführende Werke, Lehrbücher, Übersichten über das Gesamtgebiet, sonst bei entsprechenden Systemstellen, z.B. Zellbiologie WE, Molekulargenetik WG 1700 ff.)
|k Biologie
|k Biophysik, Biochemie, Physiologische Chemie
|k Molekularbiologie (hier nur einführende Werke, Lehrbücher, Übersichten über das Gesamtgebiet, sonst bei entsprechenden Systemstellen, z.B. Zellbiologie WE, Molekulargenetik WG 1700 ff.)
|0 (DE-627)127151026X
|0 (DE-625)rvk/148177:
|0 (DE-576)20151026X
|
| 936 |
r |
v |
|a WC 4150
|b Allgemeines, Praktika; "Methods of biochemical analysis"
|k Biologie
|k Methoden
|k Biochemische Methoden
|k Allgemeines, Praktika; "Methods of biochemical analysis"
|0 (DE-627)1271478439
|0 (DE-625)rvk/148092:
|0 (DE-576)201478439
|
| 936 |
b |
k |
|a 42.13
|j Molekularbiologie
|0 (DE-627)106410458
|
| 936 |
b |
k |
|a 44.41
|j Pharmazeutische Biologie
|0 (DE-627)181571781
|
| 936 |
b |
k |
|a 44.42
|j Pharmazeutische Chemie
|0 (DE-627)18157179X
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615/.7045
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 1187053937
|c 00
|f LS2
|d BE E 426 (0613)
|e b
|j --%%--
|c 09
|f --%%--
|d 2906-1509
|e --%%--
|j --%%--
|y k
|z 01-11-10
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 1178034666
|c 00
|f J 36
|d PHA:GX:5900:Fox::2010
|e d
|j --%%--
|y z
|z 25-08-10
|
| 980 |
|
|
|2 55
|1 01
|x 3055
|b 1171517521
|c 00
|f --%%--
|d E 4/07
|e --%%--
|j --%%--
|y z
|z 16-07-10
|
| 980 |
|
|
|2 69
|1 01
|x 0009
|b 1174930713
|c 00
|f UB 660
|d 660/VS 5800 F791(2)
|e c
|j --%%--
|y z
|z 21-09-10
|
| 980 |
|
|
|2 290
|1 01
|x 3290
|b 1171657676
|c 00
|f --%%--
|d MMB 613
|e c
|j --%%--
|y k
|z 19-07-10
|
| 980 |
|
|
|2 2007
|1 01
|x DE-352
|b 3249025836
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 28-10-09
|
| 983 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a PHA:GX:5900
|
| 983 |
|
|
|2 69
|1 00
|x DE-9
|8 00
|a VS 5800
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029061509
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 27$025788922
|
| 984 |
|
|
|2 69
|1 01
|x 0009
|a 9$08493812
|
| 984 |
|
|
|2 290
|1 01
|x 3290
|a D267$1039164
|
| 985 |
|
|
|2 31
|1 01
|x 0027
|a U 124609
|
| 985 |
|
|
|2 69
|1 01
|x 0009
|a 2010.11010
|
| 985 |
|
|
|2 290
|1 01
|x 3290
|a Z 12307
|
| 998 |
|
|
|2 31
|1 01
|x 0027
|a PHA 201010
|
